Skin protectant for management of incontinence-associated dermatitis
Research type
Research Study
Full title
Effects of an advanced skin protectant in the management of incontinence-associated dermatitis compared to hospital standard care practice: an exploratory randomized controlled trial
IRAS ID
243191
Contact name
David Voegeli
Contact email
Sponsor organisation
3M
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
This study is to investigate the efficiency of a newly-developed skin protection (3MTMCavilonTM high-performance skin protectant) in comparison to current standard therapy.
With the application of this product on the skin, a long-lasting, waterproof and resilient film is formed that protects the skin against moisture and the irritants contained in the body excretions. This allows the regeneration of the skin below the film.
Patients recruited to this study will be over the age of 18 and diagnosed with incontinence-associated dermatitis.
Eligible patients will already be in hospital for an in-patient stay of a minimum of 7 days and receive daily visits from a study nurse to assess and apply the study device or placebo and undertake questionnaires regarding their pain and have photo's taken of the affected area.REC name
South Central - Hampshire A Research Ethics Committee
REC reference
18/SC/0249
Date of REC Opinion
27 Jul 2018
REC opinion
Further Information Favourable Opinion